Cherry Tree Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Cherry Tree Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$562	Hold	1	–	–	﹤0.01%	560
2025 Q4	$677	Hold	1	–	–	﹤0.01%	562
2025 Q3	$639	Hold	1	–	–	﹤0.01%	559
2025 Q2	$537	Hold	1	–	–	﹤0.01%	581
2025 Q1	$420	Hold	1	–	–	﹤0.01%	733
2024 Q4	$414	Hold	1	–	–	﹤0.01%	618
2024 Q3	$506	Hold	1	–	–	﹤0.01%	590
2024 Q2	$488	Hold	1	–	–	﹤0.01%	573
2024 Q1	$540	Hold	1	–	–	﹤0.01%	569
2023 Q4	$556	Hold	1	–	–	﹤0.01%	564
2023 Q3	$438	Hold	1	–	–	﹤0.01%	562
2023 Q2	$503	Buy	+1	New	+$479	﹤0.01%	562

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cherry Tree Wealth Management's IDXX Position: Q1 2026 in Review

Cherry Tree Wealth Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1 share worth $562. The position accounts for ﹤0.01% of the portfolio, ranked #560.

Cherry Tree Wealth Management first reported a position in IDXX in Q2 2023 and has held it in 12 quarters since. The position peaked at $677 in Q4 2025. 1,318 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Cherry Tree Wealth Management held 1 share of Idexx Laboratories worth $562 as of Q1 2026.
Cherry Tree Wealth Management left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up ﹤0.01% of Cherry Tree Wealth Management's portfolio in Q1 2026, its #560 holding.
Cherry Tree Wealth Management first reported a position in Idexx Laboratories in Q2 2023 and has held it in 12 quarters since.
Cherry Tree Wealth Management's Idexx Laboratories position peaked at $677 in Q4 2025.
1,318 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.